GREGORY K PALM Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GREGORY K PALM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY K PALM. GREGORY K PALM is Executive VP - General Counsel in GOLDMAN SACHS GROUP INC ($GS).
Latest Insider Trading Transactions of GREGORY K PALM
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 28 2018 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 78.78 | 34,956 | 2,753,834 | 0 | |
| Dec 28 2018 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 78.78 | 34,956 | 2,753,834 | 34,956 | |
| Dec 28 2018 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 159.68 | 8,306 | 1,326,302 | 946,915 | 955.2 K to 946.9 K (-0.87 %) |
| Dec 28 2018 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Payment of Exercise | F | 160.12 | 26,650 | 4,267,198 | 955,221 | 981.9 K to 955.2 K (-2.71 %) |
| Dec 28 2018 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | M | 78.78 | 34,956 | 2,753,834 | 981,871 | 946.9 K to 981.9 K (+3.69 %) |
| Dec 28 2018 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 157.12 | 8,145 | 1,279,719 | 946,915 | 955.1 K to 946.9 K (-0.85 %) |
| Dec 28 2018 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Payment of Exercise | F | 156.99 | 26,811 | 4,209,059 | 955,060 | 981.9 K to 955.1 K (-2.73 %) |
| Dec 28 2018 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | M | 78.78 | 34,956 | 2,753,834 | 981,871 | 946.9 K to 981.9 K (+3.69 %) |
| Jan 19 2018 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Payment of Exercise | F | 250.97 | 9,543 | 2,395,007 | 946,915 | 956.5 K to 946.9 K (-1.00 %) |
| Jan 19 2018 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Grant | A | 0.00 | 17,931 | 0 | 956,458 | 938.5 K to 956.5 K (+1.91 %) |
| Dec 29 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 0.00 | 25,982 | 0 | 0 | |
| Dec 29 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Payment of Exercise | F | 255.95 | 14,502 | 3,711,787 | 938,527 | 953 K to 938.5 K (-1.52 %) |
| Dec 29 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | M | 0.00 | 25,982 | 0 | 953,029 | 927 K to 953 K (+2.80 %) |
| Nov 24 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 78.78 | 34,956 | 2,753,834 | 69,912 | |
| Nov 24 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 238.01 | 10,625 | 2,528,871 | 71,281 | 81.9 K to 71.3 K (-12.97 %) |
| Nov 24 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 237.82 | 10,334 | 2,457,662 | 927,047 | 937.4 K to 927 K (-1.10 %) |
| Nov 24 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Payment of Exercise | F | 238.14 | 24,622 | 5,863,483 | 937,381 | 962 K to 937.4 K (-2.56 %) |
| Nov 24 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | M | 78.78 | 34,956 | 2,753,834 | 962,003 | 927 K to 962 K (+3.77 %) |
| Nov 22 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 204.16 | 35,786 | 7,306,070 | 0 | |
| Nov 22 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 204.16 | 35,786 | 7,306,070 | 35,786 | |
| Nov 22 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 239.28 | 2,328 | 557,050 | 927,047 | 929.4 K to 927 K (-0.25 %) |
| Nov 22 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Payment of Exercise | F | 239.42 | 33,458 | 8,010,514 | 929,375 | 962.8 K to 929.4 K (-3.47 %) |
| Nov 22 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | M | 204.16 | 35,786 | 7,306,070 | 962,833 | 927 K to 962.8 K (+3.86 %) |
| Nov 22 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 238.68 | 2,292 | 547,061 | 927,047 | 929.3 K to 927 K (-0.25 %) |
| Nov 22 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Payment of Exercise | F | 238.78 | 33,494 | 7,997,697 | 929,339 | 962.8 K to 929.3 K (-3.48 %) |
| Nov 22 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | M | 204.16 | 35,786 | 7,306,070 | 962,833 | 927 K to 962.8 K (+3.86 %) |
| Jan 26 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 0.00 | 28,581 | 0 | 0 | |
| Jan 26 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Payment of Exercise | F | 232.67 | 15,284 | 3,556,128 | 927,047 | 942.3 K to 927 K (-1.62 %) |
| Jan 26 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | M | 0.00 | 28,581 | 0 | 942,331 | 913.8 K to 942.3 K (+3.13 %) |
| Jan 20 2017 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | A | 0.00 | 19,447 | 0 | 19,447 | |
| Dec 30 2016 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Gift | G | 0.00 | 4,125 | 0 | 913,750 | 917.9 K to 913.8 K (-0.45 %) |
| Nov 17 2016 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 199.84 | 65,116 | 13,012,781 | 0 | |
| Nov 17 2016 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 210.76 | 1,493 | 314,665 | 917,875 | 919.4 K to 917.9 K (-0.16 %) |
| Nov 17 2016 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Payment of Exercise | F | 210.78 | 63,623 | 13,410,456 | 919,368 | 983 K to 919.4 K (-6.47 %) |
| Nov 17 2016 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | M | 199.84 | 65,116 | 13,012,781 | 982,991 | 917.9 K to 983 K (+7.09 %) |
| Jan 28 2016 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 0.00 | 27,965 | 0 | 0 | |
| Jan 28 2016 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Payment of Exercise | F | 151.12 | 14,954 | 2,259,848 | 921,505 | 936.5 K to 921.5 K (-1.60 %) |
| Jan 28 2016 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | M | 0.00 | 27,965 | 0 | 936,459 | 908.5 K to 936.5 K (+3.08 %) |
| Jan 22 2016 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | A | 0.00 | 31,850 | 0 | 31,850 | |
| Nov 25 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 131.64 | 10,367 | 1,364,712 | 0 | |
| Nov 25 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 131.64 | 10,368 | 1,364,844 | 10,367 | |
| Nov 25 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 131.64 | 10,368 | 1,364,844 | 20,735 | |
| Nov 25 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 189.38 | 5,310 | 1,005,616 | 908,494 | 913.8 K to 908.5 K (-0.58 %) |
| Nov 25 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 188.85 | 5,057 | 954,991 | 913,804 | 918.9 K to 913.8 K (-0.55 %) |
| Nov 25 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | M | 131.64 | 10,367 | 1,364,712 | 918,861 | 908.5 K to 918.9 K (+1.14 %) |
| Nov 25 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 189.11 | 3,296 | 623,306 | 908,494 | 911.8 K to 908.5 K (-0.36 %) |
| Nov 25 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 188.28 | 4,661 | 877,559 | 911,790 | 916.5 K to 911.8 K (-0.51 %) |
| Nov 25 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 187.42 | 2,411 | 451,861 | 916,451 | 918.9 K to 916.5 K (-0.26 %) |
| Nov 25 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | M | 131.64 | 10,368 | 1,364,844 | 918,862 | 908.5 K to 918.9 K (+1.14 %) |
| Nov 25 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 190.86 | 2,671 | 509,796 | 908,494 | 911.2 K to 908.5 K (-0.29 %) |
| Nov 25 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 190.14 | 3,987 | 758,095 | 911,165 | 915.2 K to 911.2 K (-0.44 %) |
| Nov 25 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 189.19 | 3,710 | 701,878 | 915,152 | 918.9 K to 915.2 K (-0.40 %) |
| Nov 25 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | M | 131.64 | 10,368 | 1,364,844 | 918,862 | 908.5 K to 918.9 K (+1.14 %) |
| May 20 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 131.64 | 14,326 | 1,885,875 | 31,103 | |
| May 20 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 131.64 | 1,226 | 161,391 | 45,429 | |
| May 20 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 205.00 | 14,326 | 2,936,859 | 908,494 | 922.8 K to 908.5 K (-1.55 %) |
| May 20 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | M | 131.64 | 14,326 | 1,885,875 | 922,820 | 908.5 K to 922.8 K (+1.58 %) |
| May 20 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 205.05 | 1,226 | 251,396 | 908,494 | 909.7 K to 908.5 K (-0.13 %) |
| May 20 2015 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | M | 131.64 | 1,226 | 161,391 | 909,720 | 908.5 K to 909.7 K (+0.13 %) |
| Feb 05 2010 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | A | 0.00 | 57,084 | 0 | 57,084 | |
| Jan 27 2010 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 0.00 | 23,013 | 0 | 0 | |
| Jan 27 2010 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Payment of Exercise | F | 156.40 | 11,212 | 1,753,557 | 951,543 | 962.8 K to 951.5 K (-1.16 %) |
| Jan 27 2010 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | M | 0.00 | 23,013 | 0 | 962,755 | 939.7 K to 962.8 K (+2.45 %) |
| Jan 15 2009 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 0.00 | 53,109 | 0 | 0 | |
| Jan 15 2009 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Payment of Exercise | F | 76.30 | 23,724 | 1,810,023 | 939,742 | 963.5 K to 939.7 K (-2.46 %) |
| Jan 15 2009 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | M | 0.00 | 53,109 | 0 | 963,466 | 910.4 K to 963.5 K (+5.83 %) |
| Dec 19 2008 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | A | 78.78 | 104,868 | 8,261,501 | 104,868 | |
| Dec 19 2008 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | A | 0.00 | 14,117 | 0 | 14,117 | |
| Jun 20 2008 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Gift | G | 0.00 | 47,706 | 0 | 0 | 47.7 K to 0 (-100.00 %) |
| Jun 20 2008 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | J | 0.00 | 92,587 | 0 | 910,357 | 817.8 K to 910.4 K (+11.32 %) |
| Jan 23 2008 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 147.42 | 5,256 | 774,840 | 817,770 | 823 K to 817.8 K (-0.64 %) |
| Jan 23 2008 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 142.69 | 20,630 | 2,943,695 | 823,026 | 843.7 K to 823 K (-2.45 %) |
| Jan 09 2008 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 0.00 | 9,797 | 0 | 0 | |
| Jan 09 2008 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 0.00 | 3,034 | 0 | 0 | |
| Jan 09 2008 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 0.00 | 44,428 | 0 | 0 | |
| Jan 09 2008 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Payment of Exercise | F | 195.12 | 26,541 | 5,178,680 | 843,656 | 870.2 K to 843.7 K (-3.05 %) |
| Jan 09 2008 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | M | 0.00 | 57,259 | 0 | 870,197 | 812.9 K to 870.2 K (+7.04 %) |
| Dec 21 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | A | 204.16 | 71,572 | 14,612,140 | 71,572 | |
| Dec 21 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | A | 0.00 | 3,266 | 0 | 3,266 | |
| Dec 21 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | A | 0.00 | 9,797 | 0 | 9,797 | |
| Dec 21 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | A | 0.00 | 25,037 | 0 | 25,037 | |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 232.33 | 200 | 46,466 | 812,938 | 813.1 K to 812.9 K (-0.02 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 232.27 | 1,000 | 232,270 | 813,138 | 814.1 K to 813.1 K (-0.12 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 232.26 | 300 | 69,678 | 814,138 | 814.4 K to 814.1 K (-0.04 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 232.25 | 100 | 23,225 | 814,438 | 814.5 K to 814.4 K (-0.01 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 232.24 | 500 | 116,120 | 814,538 | 815 K to 814.5 K (-0.06 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 232.22 | 900 | 208,998 | 815,038 | 815.9 K to 815 K (-0.11 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 232.21 | 100 | 23,221 | 815,938 | 816 K to 815.9 K (-0.01 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 232.20 | 500 | 116,100 | 816,038 | 816.5 K to 816 K (-0.06 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 232.19 | 8,400 | 1,950,396 | 816,538 | 824.9 K to 816.5 K (-1.02 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 232.18 | 600 | 139,308 | 824,938 | 825.5 K to 824.9 K (-0.07 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 232.03 | 100 | 23,203 | 825,538 | 825.6 K to 825.5 K (-0.01 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 232.01 | 300 | 69,603 | 825,638 | 825.9 K to 825.6 K (-0.04 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.99 | 300 | 69,597 | 825,938 | 826.2 K to 825.9 K (-0.04 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.98 | 900 | 208,782 | 826,238 | 827.1 K to 826.2 K (-0.11 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.95 | 1,900 | 440,705 | 827,138 | 829 K to 827.1 K (-0.23 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.93 | 500 | 115,965 | 829,038 | 829.5 K to 829 K (-0.06 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.91 | 600 | 139,146 | 829,538 | 830.1 K to 829.5 K (-0.07 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.89 | 500 | 115,945 | 830,138 | 830.6 K to 830.1 K (-0.06 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.87 | 300 | 69,561 | 830,638 | 830.9 K to 830.6 K (-0.04 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.86 | 100 | 23,186 | 830,938 | 831 K to 830.9 K (-0.01 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.83 | 200 | 46,366 | 831,038 | 831.2 K to 831 K (-0.02 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.81 | 1,410 | 326,852 | 831,238 | 832.6 K to 831.2 K (-0.17 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.80 | 1,700 | 394,060 | 832,648 | 834.3 K to 832.6 K (-0.20 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.79 | 800 | 185,432 | 834,348 | 835.1 K to 834.3 K (-0.10 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.72 | 100 | 23,172 | 835,148 | 835.2 K to 835.1 K (-0.01 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.71 | 2,500 | 579,275 | 835,248 | 837.7 K to 835.2 K (-0.30 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.68 | 2,000 | 463,360 | 837,748 | 839.7 K to 837.7 K (-0.24 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.67 | 100 | 23,167 | 839,748 | 839.8 K to 839.7 K (-0.01 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.66 | 200 | 46,332 | 839,848 | 840 K to 839.8 K (-0.02 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.65 | 400 | 92,660 | 840,048 | 840.4 K to 840 K (-0.05 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.64 | 800 | 185,312 | 840,448 | 841.2 K to 840.4 K (-0.10 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.63 | 1,300 | 301,119 | 841,248 | 842.5 K to 841.2 K (-0.15 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.62 | 900 | 208,458 | 842,548 | 843.4 K to 842.5 K (-0.11 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.60 | 300 | 69,480 | 843,448 | 843.7 K to 843.4 K (-0.04 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.59 | 1,168 | 270,497 | 843,748 | 844.9 K to 843.7 K (-0.14 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.58 | 722 | 167,201 | 844,916 | 845.6 K to 844.9 K (-0.09 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.57 | 300 | 69,471 | 845,638 | 845.9 K to 845.6 K (-0.04 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.56 | 1,300 | 301,028 | 845,938 | 847.2 K to 845.9 K (-0.15 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.55 | 1,000 | 231,550 | 847,238 | 848.2 K to 847.2 K (-0.12 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.54 | 2,200 | 509,388 | 848,238 | 850.4 K to 848.2 K (-0.26 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.53 | 1,400 | 324,142 | 850,438 | 851.8 K to 850.4 K (-0.16 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.52 | 500 | 115,760 | 851,838 | 852.3 K to 851.8 K (-0.06 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.51 | 900 | 208,359 | 852,338 | 853.2 K to 852.3 K (-0.11 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.50 | 300 | 69,450 | 853,238 | 853.5 K to 853.2 K (-0.04 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.49 | 300 | 69,447 | 853,538 | 853.8 K to 853.5 K (-0.04 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.48 | 200 | 46,296 | 853,838 | 854 K to 853.8 K (-0.02 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.46 | 1,800 | 416,628 | 854,038 | 855.8 K to 854 K (-0.21 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.45 | 1,100 | 254,595 | 855,838 | 856.9 K to 855.8 K (-0.13 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.43 | 500 | 115,715 | 856,938 | 857.4 K to 856.9 K (-0.06 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.42 | 1,000 | 231,420 | 857,438 | 858.4 K to 857.4 K (-0.12 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.41 | 1,100 | 254,551 | 858,438 | 859.5 K to 858.4 K (-0.13 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.40 | 500 | 115,700 | 859,538 | 860 K to 859.5 K (-0.06 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.39 | 700 | 161,973 | 860,038 | 860.7 K to 860 K (-0.08 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.38 | 700 | 161,966 | 860,738 | 861.4 K to 860.7 K (-0.08 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.36 | 500 | 115,680 | 861,438 | 861.9 K to 861.4 K (-0.06 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.26 | 200 | 46,252 | 861,938 | 862.1 K to 861.9 K (-0.02 %) |
| Oct 30 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 231.25 | 800 | 185,000 | 862,138 | 862.9 K to 862.1 K (-0.09 %) |
| Jun 19 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Buy | J | 0.00 | 59,707 | 0 | 862,938 | 803.2 K to 862.9 K (+7.43 %) |
| Jan 22 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | J | 0.00 | 13,520 | 0 | 803,231 | 816.8 K to 803.2 K (-1.66 %) |
| Jan 08 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 0.00 | 10,009 | 0 | 0 | |
| Jan 08 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | M | 0.00 | 38,464 | 0 | 0 | |
| Jan 08 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Payment of Exercise | F | 199.37 | 22,469 | 4,479,645 | 816,751 | 839.2 K to 816.8 K (-2.68 %) |
| Jan 08 2007 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Grant | A | 0.00 | 48,473 | 0 | 839,220 | 790.7 K to 839.2 K (+6.13 %) |
| Dec 19 2006 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | A | 199.84 | 65,116 | 13,012,781 | 65,116 | |
| Dec 19 2006 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | A | 0.00 | 13,346 | 0 | 13,346 | |
| Dec 19 2006 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Option Exercise | A | 0.00 | 25,009 | 0 | 25,009 | |
| Jul 21 2006 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 147.06 | 1,000 | 147,060 | 42,500 | 43.5 K to 42.5 K (-2.30 %) |
| Jul 21 2006 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 147.32 | 3,400 | 500,888 | 43,500 | 46.9 K to 43.5 K (-7.25 %) |
| Jul 21 2006 | GS | GOLDMAN SACHS GROU ... | PALM GREGORY K | Executive VP - Gene ... | Sell | S | 147.33 | 1,600 | 235,728 | 46,900 | 48.5 K to 46.9 K (-3.30 %) |